Longbow Capital

Clir Renewables Inc. specializes in developing cloud-based software for renewable energy asset management and reporting. Founded in 2016 and headquartered in Vancouver, Canada, with an office in Glasgow, United Kingdom, Clir's software-as-a-service platform aims to enhance the performance and profitability of renewable energy plants. By integrating advanced artificial intelligence with deep domain expertise, the platform assists asset managers and owners in optimizing annual energy production, monitoring asset health, and managing both financial and technical risks.

VoltaGrid LLC, based in Bellaire, Texas, operates in the energy sector and specializes in advanced energy management and generation solutions. Founded in 2020, the company focuses on improving power quality and reliability through a portable and scalable power platform that integrates natural gas and grid power. VoltaGrid aims to transform mobile power generation by providing clean, efficient energy solutions for clients in industries such as pressure pumping, remote mining, utilities, and distributed generation. By utilizing its innovative technology, VoltaGrid enables clients to achieve significant reductions in emissions and fuel consumption.

Domainex Ltd. is a biotechnology company based in Saffron Walden, United Kingdom, that specializes in contract research and manufacturing services focused on drug discovery. Established in 2001, the company provides a comprehensive range of services, including medicinal and computational chemistry, protein expression and purification, biochemical assay development, and DMPK analysis. Domainex is known for its expertise in developing advanced medicines through innovative technologies, including biochemical binding techniques, particularly for oncology drugs and treatments for inflammatory diseases. The company has a significant emphasis on hit identification and candidate drug synthesis, utilizing both virtual and fragment-based approaches to address complex drug discovery challenges. In 2007, Domainex merged with NCE Discovery, enhancing its capabilities in both biological and chemical research.